News | April 25, 2026
Bayer’s comeback gains speed as CEO warns: “The Work Isn’t Complete. Yet"
The Pharmaceuticals portfolio and pipeline are more promising than perhaps ever before
The Pharmaceuticals portfolio and pipeline are more promising than perhaps ever before
New facility offers genetic testing, counselling and personalised treatment plans to enable early diagnosis and precision-led care
Extending production capabilities to the Americas helps reduce labor costs and inventory complexity for nutraceuticals and other industries while maintaining superior moisture control
The investigational therapy, MDX2003, is designed to go after cancer cells with a multi-pronged immune attack
The system is powered by BrainSense technology, which has received approval from USFDA
New formulation by Greenspace Herbs to target improved efficacy and lower dosage in curcumin supplements
Stakeholders call for coordinated action on diagnostics, vaccines, and health system readiness as the monsoon season approaches
C. P. Radhakrishnan urged graduates to uphold ethical standards and maintain a commitment to patient care
The collaboration underscores a broader industry shift toward hybrid research models that integrate computational biology with advanced experimental systems
While many cases are treatable, a subset can become highly aggressive, spreading to distant organs and resisting conventional therapies
Subscribe To Our Newsletter & Stay Updated
